Silchester International Investors LLP decreased its stake in Nutrien Ltd. (NYSE:NTR - Free Report) by 9.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,634,539 shares of the company's stock after selling 1,058,598 shares during the quarter. Nutrien makes up about 94.8% of Silchester International Investors LLP's investment portfolio, making the stock its largest position. Silchester International Investors LLP owned 2.18% of Nutrien worth $528,218,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also bought and sold shares of the company. Strategic Financial Concepts LLC acquired a new stake in shares of Nutrien in the 4th quarter valued at $210,000. Van ECK Associates Corp boosted its position in Nutrien by 5.7% in the fourth quarter. Van ECK Associates Corp now owns 1,480,870 shares of the company's stock valued at $66,264,000 after buying an additional 80,382 shares in the last quarter. Grace & White Inc. NY boosted its position in Nutrien by 9.5% in the fourth quarter. Grace & White Inc. NY now owns 109,200 shares of the company's stock valued at $4,887,000 after buying an additional 9,500 shares in the last quarter. V Square Quantitative Management LLC boosted its position in Nutrien by 28.5% in the fourth quarter. V Square Quantitative Management LLC now owns 10,115 shares of the company's stock valued at $453,000 after buying an additional 2,243 shares in the last quarter. Finally, Asset Planning Inc acquired a new position in shares of Nutrien in the 4th quarter worth approximately $35,000. Institutional investors and hedge funds own 63.10% of the company's stock.
Nutrien Trading Up 3.4%
NTR traded up $2.04 during mid-day trading on Friday, hitting $62.48. The stock had a trading volume of 3,055,977 shares, compared to its average volume of 2,166,023. The stock's fifty day simple moving average is $56.03 and its 200-day simple moving average is $51.84. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The firm has a market capitalization of $30.47 billion, a price-to-earnings ratio of 45.68, a price-to-earnings-growth ratio of 1.19 and a beta of 0.81. Nutrien Ltd. has a 1-year low of $43.70 and a 1-year high of $62.73.
Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.24). The business had revenue of $4.67 billion for the quarter, compared to analyst estimates of $5.16 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The business's quarterly revenue was down 5.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.46 EPS. As a group, research analysts forecast that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.
Nutrien Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, July 18th. Shareholders of record on Monday, June 30th will be issued a dividend of $0.545 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $2.18 annualized dividend and a yield of 3.49%. Nutrien's dividend payout ratio (DPR) is currently 203.74%.
Analysts Set New Price Targets
Several research analysts have recently commented on NTR shares. Royal Bank of Canada boosted their target price on Nutrien from $60.00 to $65.00 and gave the stock an "outperform" rating in a report on Monday, May 12th. TD Securities boosted their price objective on Nutrien from $64.00 to $67.00 and gave the stock a "buy" rating in a research note on Monday, May 12th. Wells Fargo & Company upped their price target on shares of Nutrien from $56.00 to $59.00 and gave the stock an "equal weight" rating in a research report on Monday, May 12th. UBS Group upped their price target on shares of Nutrien from $52.00 to $56.00 and gave the stock a "neutral" rating in a research report on Thursday, May 8th. Finally, Bank of America upped their price objective on Nutrien from $60.00 to $63.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Nutrien presently has an average rating of "Hold" and a consensus price target of $61.44.
View Our Latest Stock Analysis on Nutrien
Nutrien Company Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Recommended Stories

Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.